Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after plati... by Leal, Ticiana, MD, Kotecha, Rupesh, Prof, Ramlau, Rodryg, MD, Zhang, Li, MD, Milanowski, Janusz, Prof, Cobo, Manuel, MD, Roubec, Jaromir, MD, Petruzelka, Lubos, MD, Havel, Libor, MD, Kalmadi, Sujith, MD, Ward, Jeffrey, MD, Andric, Zoran, MD, Berghmans, Thierry, MD, Gerber, David E, Prof, Kloecker, Goetz, MD, Panikkar, Rajiv, Prof, Aerts, Joachim, MD, Delmonte, Angelo, MD, Pless, Miklos, Prof, Greil, Richard, Prof, Rolfo, Christian, Prof, Akerley, Wallace, Prof, Eaton, Michael, MD, Iqbal, Mussawar, MD, Langer, Corey, Prof

Get full text

A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC by Camidge, D. Ross, MD, PhD, Barlesi, Fabrice, MD, PhD, Goldman, Jonathan W., MD, Morgensztern, Daniel, MD, Heist, Rebecca, MD, MPH, Vokes, Everett, MD, Angevin, Eric, MD, PhD, Hong, David S., MD, Rybkin, Igor I., MD, Barve, Minal, MD, Bauer, Todd M., MD, Delmonte, Angelo, MD, Dunbar, Martin, DrPH, Motwani, Monica, PhD, Parikh, Apurvasena, PhD, Noon, Elysa, PhD, Wu, Jun, MD, Blot, Vincent, PhD, Kelly, Karen, MD

Get full text

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updat... by Goldman, Jonathan W, MD, Dvorkin, Mikhail, MD, Chen, Yuanbin, MD, Reinmuth, Niels, MD, Hotta, Katsuyuki, Prof, Trukhin, Dmytro, MD, Statsenko, Galina, MD, Hochmair, Maximilian J, MD, Özgüroğlu, Mustafa, Prof, Ji, Jun Ho, MD, Garassino, Marina Chiara, MD, Voitko, Oleksandr, MD, Poltoratskiy, Artem, MD, Ponce, Santiago, MD, Verderame, Francesco, MD, Havel, Libor, MD, Bondarenko, Igor, Prof, Każarnowicz, Andrzej, MD, Losonczy, György, Prof, Conev, Nikolay V, MD, Armstrong, Jon, MSc, Byrne, Natalie, BSc, Thiyagarajah, Piruntha, MD, Jiang, Haiyi, MD, Paz-Ares, Luis, Prof

Get full text